XKRX:067080 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
12280.00
(-4.58%)
Nov 29
Business Description
Dae Hwa Pharm Co Ltd
ISIN : KR7067080002
Share Class Description:
XKRX:067080: Ordinary SharesCompare
Compare
Traded in other countries / regions
067080.Korea IPO Date
2003-02-14Description
Dae Hwa Pharm Co Ltd is a specialized pharmaceutical company. It is mainly involved in manufacturing and distribution of pharmaceutical products. The company controls approximately 70% of the domestic transdermal drug delivery system market. The company offers analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs. Its products are exported to Asia, South America, Africa, and the Middle East.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.14 | |||||
| Equity-to-Asset | 0.32 | |||||
| Debt-to-Equity | 1.55 | |||||
| Debt-to-EBITDA | 9.69 | |||||
| Interest Coverage | 0.53 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 1.62 | |||||
| Beneish M-Score | -2.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.2 | |||||
| 3-Year EBITDA Growth Rate | -1.3 | |||||
| 3-Year EPS without NRI Growth Rate | 8.7 | |||||
| 3-Year FCF Growth Rate | -12.3 | |||||
| 3-Year Book Growth Rate | -3.8 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.64 | |||||
| 9-Day RSI | 30.94 | |||||
| 14-Day RSI | 36.06 | |||||
| 6-1 Month Momentum % | 74.59 | |||||
| 12-1 Month Momentum % | 95.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.54 | |||||
| Quick Ratio | 0.3 | |||||
| Cash Ratio | 0.12 | |||||
| Days Inventory | 107.9 | |||||
| Days Sales Outstanding | 50.36 | |||||
| Days Payable | 56.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.22 | |||||
| Forward Dividend Yield % | 1.22 | |||||
| 5-Year Yield-on-Cost % | 1.22 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | -2.79 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 32.71 | |||||
| Operating Margin % | 1.97 | |||||
| Net Margin % | -1.08 | |||||
| FCF Margin % | -1.27 | |||||
| ROE % | -2.24 | |||||
| ROA % | -0.74 | |||||
| ROIC % | 0.9 | |||||
| ROC (Joel Greenblatt) % | 3.77 | |||||
| ROCE % | 5.07 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.45 | |||||
| PB Ratio | 3.09 | |||||
| Price-to-Tangible-Book | 5.27 | |||||
| Price-to-Operating-Cash-Flow | 39.93 | |||||
| EV-to-EBIT | 67.97 | |||||
| EV-to-EBITDA | 27.64 | |||||
| EV-to-Revenue | 2.08 | |||||
| EV-to-FCF | -168.94 | |||||
| Price-to-Median-PS-Value | 0.69 | |||||
| Earnings Yield (Greenblatt) % | 1.47 | |||||
| FCF Yield % | -0.88 | |||||
| Forward Rate of Return (Yacktman) % | -21.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dae Hwa Pharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 147,789.23 | ||
| EPS (TTM) (â‚©) | -90 | ||
| Beta | -0.04 | ||
| Volatility % | 61.58 | ||
| 14-Day RSI | 36.06 | ||
| 14-Day ATR (â‚©) | 909.032355 | ||
| 20-Day SMA (â‚©) | 13594.5 | ||
| 12-1 Month Momentum % | 95.6 | ||
| 52-Week Range (â‚©) | 8290 - 24150 | ||
| Shares Outstanding (Mil) | 17.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dae Hwa Pharm Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dae Hwa Pharm Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dae Hwa Pharm Co Ltd Frequently Asked Questions
What is Dae Hwa Pharm Co Ltd(XKRX:067080)'s stock price today?
The current price of XKRX:067080 is â‚©12280.00. The 52 week high of XKRX:067080 is â‚©24150.00 and 52 week low is â‚©8290.00.
When is next earnings date of Dae Hwa Pharm Co Ltd(XKRX:067080)?
The next earnings date of Dae Hwa Pharm Co Ltd(XKRX:067080) is .
Does Dae Hwa Pharm Co Ltd(XKRX:067080) pay dividends? If so, how much?
The Dividend Yield %  of Dae Hwa Pharm Co Ltd(XKRX:067080) is 1.22% (As of Today), Highest Dividend Payout Ratio of Dae Hwa Pharm Co Ltd(XKRX:067080) was 3.3. The lowest was 0.21. And the median was 0.57. The  Forward Dividend Yield % of Dae Hwa Pharm Co Ltd(XKRX:067080) is 1.22%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers